UBS Group’s ATAI Life Sciences ATAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.9M | Buy |
7,699,759
+2,164,277
| +39% | +$4.74M | ﹤0.01% | 2003 |
|
|
2025
Q1 | $7.53M | Buy |
5,535,482
+3,596,374
| +185% | +$4.89M | ﹤0.01% | 2621 |
|
|
2024
Q4 | $2.58M | Buy |
1,939,108
+1,912,722
| +7,249% | +$2.54M | ﹤0.01% | 3514 |
|
|
2024
Q3 | $30.6K | Sell |
26,386
-942
| -3% | -$1.09K | ﹤0.01% | 5919 |
|
|
2024
Q2 | $36.3K | Buy |
27,328
+2,450
| +10% | +$3.26K | ﹤0.01% | 5782 |
|
|
2024
Q1 | $49K | Sell |
24,878
-6,005
| -19% | -$11.8K | ﹤0.01% | 5354 |
|
|
2023
Q4 | $43.5K | Buy |
30,883
+1,228
| +4% | +$1.73K | ﹤0.01% | 5419 |
|
|
2023
Q3 | $38.3K | Hold |
29,655
| – | – | ﹤0.01% | 5335 |
|
|
2023
Q2 | $51K | Sell |
29,655
-100
| -0.3% | -$172 | ﹤0.01% | 5405 |
|
|
2023
Q1 | $53.9K | Sell |
29,755
-3,162
| -10% | -$5.72K | ﹤0.01% | 5319 |
|
|
2022
Q4 | $87.6K | Buy |
32,917
+3,462
| +12% | +$9.21K | ﹤0.01% | 5099 |
|
|
2022
Q3 | $98K | Sell |
29,455
-364
| -1% | -$1.21K | ﹤0.01% | 4671 |
|
|
2022
Q2 | $109K | Buy |
29,819
+10,621
| +55% | +$38.8K | ﹤0.01% | 4371 |
|
|
2022
Q1 | $98K | Sell |
19,198
-530
| -3% | -$2.71K | ﹤0.01% | 4927 |
|
|
2021
Q4 | $150K | Buy |
19,728
+19,428
| +6,476% | +$148K | ﹤0.01% | 4878 |
|
|
2021
Q3 | $4K | Buy |
300
+200
| +200% | +$2.67K | ﹤0.01% | 7473 |
|
|
2021
Q2 | $2K | Buy |
+100
| New | +$2K | ﹤0.01% | 7814 |
|